ProQR Therap (PRQR)
ProQR Therapeutics N.V., a clinical-stage biotechnology company, focuses on the discovery and development of novel therapeutic medicines. The company develops a...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
ProQR Therap Analyst Rating
View moreForecast & Rating
Sep 9, 2026Price forecast
$8.22335.04%
Forecast & RatingStrong buy
9analysts
- Strong buy88.89%
- Buy11.11%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- Quartr · Sep 9 at 04:38 PM
PRQR: AX-0811 entered the clinic, with five trial readouts and major AI-driven advances expected this year
- Unusual Whales · Sep 9 at 12:02 PM
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
- Global Report · Sep 8 at 11:33 AM
Commercial Expansions and Late-Stage Pipeline Milestones Drive 2026 Sector Growth
- Global Report · Sep 8 at 09:19 AM
Inside the Broad Sector Reshuffle: Medtronic, Estée Lauder, and 8 Other Moves to Watch
- PUBT · Sep 1 at 07:30 AM
ProQR Therapeutics held annual shareholder meeting in Amsterdam
